Sutton Wealth Advisors Inc. Enanta Pharmaceuticals Inc Transaction History

Sutton Wealth Advisors Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$38.82 - $54.59 $19,759 - $27,786	-509 Closed	0 $0
Q4 2022 Nov 07, 2023	BUY	$40.77 - $53.73 $40 - $53	1 Added 0.2%	509 $23.7 Million
Q3 2022 Nov 07, 2023	BUY	$48.29 - $71.27 $144 - $213	3 Added 0.59%	508 $26.4 Million
Q2 2022 Nov 07, 2023	SELL	$38.13 - $76.93 $228 - $461	-6 Reduced 1.17%	505 $23.9 Million
Q1 2022 Nov 07, 2023	BUY	$56.06 - $74.11 $56 - $74	1 Added 0.2%	511 $36.4 Million
Q4 2021 Nov 07, 2023	BUY	$60.19 - $97.37 $300 - $486	5 Added 0.99%	510 $38.1 Million
Q3 2021 Nov 07, 2023	BUY	$41.02 - $58.65 $533 - $762	13 Added 2.64%	505 $28.7 Million
Q2 2016 Nov 06, 2023	BUY	N/A	492	492 $10.8 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.